<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/24E204CD-473D-4D0E-978E-5C49B0464A07"><gtr:id>24E204CD-473D-4D0E-978E-5C49B0464A07</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Griffiths</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105161071"><gtr:id>404465F0-3530-4ED5-AEDA-7EB55DA6112A</gtr:id><gtr:title>In vitro compartmentalisation (IVC) for the directed evolution of enzymes and other proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105161071</gtr:grantReference><gtr:abstractText>Enzymes are proteins which accelerate chemical reactions. Many enzymes can speed up chemical reactions more than one million, million times (1,000,000,000,000 times). Usually enzymes are exquisitely specific in the chemical transformations they perform, yielding very few by-products. Some proteins do not accelerate reactions, but do other things, for example antibodies are part of the immune system and bind foreign molecules targeting them for destruction. All natural proteins were created by millions of years of Darwinian evolution, new proteins being created by a process of mutation followed by selection. We are developing a system for the creation of new proteins, primarily enzymes, using a Darwinian process on the laboratory bench in just weeks rather than millions of years.</gtr:abstractText><gtr:technicalSummary>Proteins have many therapeutic, diagnostic and other commercial applications. The aim of this research program is to harness the power of Darwinian selection and evolution in the laboratory to generate novel and improved proteins (especially enzymes) with potential applications in all these areas.||Recently, several very effective procedures have been developed which use repertoire selection technologies and in vitro evolution to generating proteins with new and improved binding activities. Unfortunately, these technologies are very limited in their ability to select enzymes - perhaps the most important and useful biomolecules. ||We have developed a system, in vitro compartmentalisation (IVC), which should enable the selection and in vitro evolution of proteins and nucleic acids with a wide range of biological activities, including catalysis, binding and regulation. All evolutionary systems, whether in nature or in the laboratory, must link genotype to phenotype in some way. IVC is unique in that uses the same system to link genotype and phenotype as nature, i.e. compartmentalisation. In nature the compartments are cells, but in IVC the compartments are aqueous droplets in a water-in-oil emulsion of about the same size as a bacterial cell. In nature, this very flexible way of linking genotype to phenotype has allowed the evolution of a vast range of natural molecules with diverse activities and IVC should allow the selection of molecules with similarly diverse activities in vitro.</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>113939</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Invention describes a method for screening large libraries of molecules using two phase emulsions. The positives are selected by the change of optical characteristic of the genetic elements separated in individual compartments. Patent granted</gtr:description><gtr:grantRef>MC_U105161071</gtr:grantRef><gtr:id>A74E6C93-BDB1-4863-965C-4B374DF436AE</gtr:id><gtr:impact>Invention describes a method for screening large libraries of molecules using two phase emulsions. The positives are selected by the change of optical characteristic of the genetic elements separated in individual compartments. Patent granted</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>87962826025</gtr:outcomeId><gtr:patentId>EP1522582</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Optical Sorting Method</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A method for increasing the concentration of a nucleic acid molecule</gtr:description><gtr:grantRef>MC_U105161071</gtr:grantRef><gtr:id>993ED589-82EC-4CD5-B0B9-05734328ADE7</gtr:id><gtr:impact>Not known</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>C8KwtDT584D</gtr:outcomeId><gtr:patentId>EP1482036</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Increasing concentrations method</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Invention describes a method for screening large libraries of molecules using two phase emulsions. The positives are selected by the change of optical characteristic in their compartments Patent granted</gtr:description><gtr:grantRef>MC_U105161071</gtr:grantRef><gtr:id>C0A8B31F-B528-48D3-992D-EC9B0DA559EB</gtr:id><gtr:impact>Not known</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>07688983299</gtr:outcomeId><gtr:patentId>EP1496120</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>In Vitro Sorting Method</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9D4F7433-5CBA-4C74-AA6E-8EFE49649D68</gtr:id><gtr:title>Selective gene amplification.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5fd83f5885e9eafd6a6f94ade50b452"><gtr:id>a5fd83f5885e9eafd6a6f94ade50b452</gtr:id><gtr:otherNames>Kelly BT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>ED92BBEE825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67CBB828-5215-43B4-A0F6-24E987F3C54F</gtr:id><gtr:title>Amplification of complex gene libraries by emulsion PCR.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6682b85c220c8c8bd534e7066c4856a9"><gtr:id>6682b85c220c8c8bd534e7066c4856a9</gtr:id><gtr:otherNames>Williams R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>E938195BC84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FFC0B5B-7786-42AE-AE54-18CE54505C3A</gtr:id><gtr:title>Directed evolution by in vitro compartmentalization.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf3879b3fdba84ced89f0f7b94175f89"><gtr:id>bf3879b3fdba84ced89f0f7b94175f89</gtr:id><gtr:otherNames>Miller OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>4432A4F8C4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA00011C-DBC4-45A9-A408-A537541F9BF4</gtr:id><gtr:title>Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5611a8866272c43f1905aa8757afe23f"><gtr:id>5611a8866272c43f1905aa8757afe23f</gtr:id><gtr:otherNames>Brise?o-Roa L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>8CB3D367C4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69FDDA1D-5650-4D3B-AA75-E967245923A2</gtr:id><gtr:title>Droplets as microreactors for high-throughput biology.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0ba0c716df7a29f24d8e4eee83bc14b"><gtr:id>b0ba0c716df7a29f24d8e4eee83bc14b</gtr:id><gtr:otherNames>Taly V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>4C5DD750ABA</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105161071</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>